METHOD FOR PREDICTING COURSE OF PNEUMONIA WITH ALVEOLAR TYPE OF LUNG TISSUE INFILTRATION Russian patent published in 2021 - IPC G01N33/50 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to therapy. The method for predicting the course of pneumonia is to study a general blood test before and after treatment. At the same time, the amount of C-reactive protein, the activity of catalase, superoxide dismutase, elastase- and trypsin-like proteinases, the activity of a1-proteinase inhibitor, the level of TBA-active compounds, the concentration of bityrosine are additionally determined in the blood serum, and the discriminant functions of Y1 and Y2 are calculated. With a value of Y1 greater than Y2, a decrease in the number of white blood cells by 30% or more, the activity of elastase-like proteinases by 35% or more, the activity of trypsin-like proteinases by 40% or more, the number of eosinophils by 50% or more, ESR by 50% or more, the amount of C-reactive protein by 50% or more, the activity of SOD by 50% or more, the level of TBA-active compounds by 50% or more, the concentration of bityrosine by 50% or more in comparison with the level before treatment, and also with an increase of 20% or more in the activity of the a1-proteinase inhibitor after treatment relative to 30.2±3.1 IU/ml, the prognosis of pneumonia with alveolar infiltration is considered favorable.

EFFECT: invention provides increased accuracy of the prognosis.

1 cl, 1 ex, 4 tbl